financetom
Business
financetom
/
Business
/
BRIEF-Smithfield Foods Inc Files For IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Smithfield Foods Inc Files For IPO
Jan 6, 2025 9:25 AM

Jan 6 (Reuters) - SMITHFIELD FOODS INC:

* SMITHFIELD FOODS INC FILES FOR IPO - SEC FILING

* SMITHFIELD FOODS INC - APPLIES TO LIST ON NASDAQ GLOBAL

SELECT

MARKET UNDER 'SFD'

* SMITHFIELD FOODS INC SAYS CITIGROUP, UBS INVESTMENT BANK,

BNP

PARIBAS, HSBC ARE AMONG UNDERWRITERS TO IPO

* SMITHFIELD FOODS SAYS MORGAN STANLEY, BOFA SECURITIES,

GOLDMAN

SACHS & CO. LLC, BARCLAYS ARE UNDERWRITERS TO IPO

* SMITHFIELD FOODS INC - AS OF DEC 29, 2024, ALL SHARES OF

COMMON

STOCK OUTSTANDING ARE HELD BY ONE SHAREHOLDER: SFDS UK HOLDINGS

LIMITED

Source text:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Perspective Therapeutics Appoints Juan Graham as CFO; Shares Fall
Perspective Therapeutics Appoints Juan Graham as CFO; Shares Fall
Jan 6, 2025
10:18 AM EST, 01/06/2025 (MT Newswires) -- Perspective Therapeutics ( CATX ) said Monday that it appointed Juan Graham as chief financial officer, effective immediately. Graham succeeds Jonathan Hunt, who will continue working as chief accounting officer, the company said. Graham most recently served as CFO of FibroGen ( FGEN ) , Perspective Therapeutics ( CATX ) said. Shares of...
BRIEF-Lifeway Foods Responds To Letter From Danone
BRIEF-Lifeway Foods Responds To Letter From Danone
Jan 6, 2025
Jan 6 (Reuters) - Lifeway Foods Inc ( LWAY ): * LIFEWAY FOODS RESPONDS TO LETTER FROM DANONE REAFFIRMING REJECTION OF UNSOLICITED TAKEOVER OFFER AND THAT 1999 STOCKHOLDER AGREEMENT SHOULD BE VOIDED FOR VIOLATING ILLINOIS LAW Source text: Further company coverage: ...
BRIEF-Teoxane SA Announces Superior Proposal To Acquire Revance Therapeutics For $3.60 Per Share In Cash
BRIEF-Teoxane SA Announces Superior Proposal To Acquire Revance Therapeutics For $3.60 Per Share In Cash
Jan 6, 2025
Jan 6 (Reuters) - Revance Therapeutics Inc ( RVNC ): * TEOXANE SA ANNOUNCES SUPERIOR PROPOSAL TO ACQUIRE REVANCE THERAPEUTICS FOR $3.60 PER SHARE IN CASH * TEOXANE: PREPARED TO TRANSACT PROMPTLY * TEOXANE: DOES NOT ANTICIPATE ANY SIGNIFICANT REGULATORY RISKS OR DELAYS FOR POTENTIAL REVANCE DEAL Source text: Further company coverage: ...
BRIEF-Arthur J. Gallagher & Co. Acquires Encore Group
BRIEF-Arthur J. Gallagher & Co. Acquires Encore Group
Jan 6, 2025
Jan 6 (Reuters) - Arthur J. Gallagher & Co. ( AJG ): * ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES ENCORE GROUP * ARTHUR J. GALLAGHER & CO. ( AJG ) - TERMS OF THE TRANSACTION NOT DISCLOSED Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved